Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents
Ulrikka Nygaard, Mette Holm, Cathrine Bohnstedt, Qing Chai, Lisbeth Samsø Schmidt, Ulla Birgitte Hartling, Jens Jakob Herrche Petersen, Jesper Thaarup, Jesper Bjerre, Niels Grove Vejlstrup, Klaus Juul, Lone Graff Stensballe
Abstract
In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.
Topics & Concepts
MyopericarditisMedicineVaccinationIncidence (geometry)DanishPediatricsEpidemiologyProspective cohort studyMulticenter studyDemographyPericarditisCohort studyYoung adultViral diseaseMyocarditisImmunologyPericarditis and Cardiac TamponadeSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology Research